Form 8-K TENET HEALTHCARE CORP For: Oct 29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St futures muted as investors monitor US-Iran negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Wolfe Research Reiterates Outperform Rating on Tenet Healthcare (THC)
October 29, 2024 10:08 AM EDTWolfe Research analyst Justin Lake reiterated an Outperform rating and $178.00 price target on Tenet Healthcare (NYSE: THC).
The analyst comments "THC 3Q24 Beat on Strong SS Volume / Revenue Growth in Hospitals - THC reported 3Q24 rev of $5.12B, up 1.2% y/y ~1% above expectations. Adj. EBITDA of $978M up... More
